Prosztatarák: vizsgálatok itt: Észtország

3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  Where

  Parnu Linn, Tallinn, Tartu Linn

  Életkor

  18 év and over

  People

  1314 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06136650 · EU 2023-504957-11-00
• 3. fázisTaking people
  Impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy

  Where

  Tartu Linn

  Életkor

  18 év and over

  People

  400 worldwide

  Run by

  Pirkanmaan hyvinvointialue

  See details and how to join2024-517854-91-00 · EU 2024-517854-91-00
• 1/2. fázisNot yet taking people in Észtország
  Sequential Chemotherapy regimen with vinorelbine and cisplatin plus PET-guided stereotactic ablative radiotherapy (SABR) for castration- and taxane-resistant Prostate cancer (ChemSABR Prostate)

  Where

  Tartu Linn

  Életkor

  18 év and over

  People

  80

  Run by

  Tartu University Hospital

  See details and how to join2025-521551-23-01 · EU 2025-521551-23-01